• This record comes from PubMed

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

. 2020 Dec 10 ; 183 (6) : 1617-1633.e22. [epub] 20201130

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.

Grant support
PJT-156086 CIHR - Canada
FDN-154307 CIHR - Canada
P41 RR000862 NCRR NIH HHS - United States
MOP-286756 CIHR - Canada
MR/M00094X/1 Medical Research Council - United Kingdom
R00 CA201592 NCI NIH HHS - United States
R01 CA219943 NCI NIH HHS - United States
P50 CA165962 NCI NIH HHS - United States
P01 CA196539 NCI NIH HHS - United States
R01 CA159859 NCI NIH HHS - United States
R01 CA215489 NCI NIH HHS - United States
R01 CA148699 NCI NIH HHS - United States

Links

PubMed 33259802
PubMed Central PMC7791404
DOI 10.1016/j.cell.2020.11.012
PII: S0092-8674(20)31529-4
Knihovny.cz E-resources

Histone H3.3 glycine 34 to arginine/valine (G34R/V) mutations drive deadly gliomas and show exquisite regional and temporal specificity, suggesting a developmental context permissive to their effects. Here we show that 50% of G34R/V tumors (n = 95) bear activating PDGFRA mutations that display strong selection pressure at recurrence. Although considered gliomas, G34R/V tumors actually arise in GSX2/DLX-expressing interneuron progenitors, where G34R/V mutations impair neuronal differentiation. The lineage of origin may facilitate PDGFRA co-option through a chromatin loop connecting PDGFRA to GSX2 regulatory elements, promoting PDGFRA overexpression and mutation. At the single-cell level, G34R/V tumors harbor dual neuronal/astroglial identity and lack oligodendroglial programs, actively repressed by GSX2/DLX-mediated cell fate specification. G34R/V may become dispensable for tumor maintenance, whereas mutant-PDGFRA is potently oncogenic. Collectively, our results open novel research avenues in deadly tumors. G34R/V gliomas are neuronal malignancies where interneuron progenitors are stalled in differentiation by G34R/V mutations and malignant gliogenesis is promoted by co-option of a potentially targetable pathway, PDGFRA signaling.

2nd Department of Paediatrics Semmelweis University Budapest 1094 Hungary

Canadian Centre for Computational Genomics McGill University Montreal QC H3A 0E9 Canada

Cancer Research Program The Research Institute of the McGill University Health Centre Montreal QC H4A 3J1 Canada; Division of Orthopedic Surgery Faculty of Surgery McGill University Montreal QC H3G 1A4 Canada

Children's Cancer Center The Royal Children's Hospital; and Murdoch Children's Research Institute; Parkville VIC 3052 Australia

Children's Cancer Center The Royal Children's Hospital; Murdoch Children's Research Institute; Department of Pediatrics University of Melbourne Parkville VIC 3052 Australia

Clinical Cooperation Unit Neuropathology German Cancer Consortium Heidelberg 69120 Germany

Dana Farber Boston Children's Cancer and Blood Disorders Center Boston MA 02215 USA

Dana Farber Boston Children's Cancer and Blood Disorders Center Boston MA 02215 USA; Department of Medical Oncology Dana Farber Cancer Institute Boston MA 02215 5450 USA; Department of Pediatrics Harvard Medical School Boston MA 02115 USA

Department of Biochemistry and Biophysics and Penn Epigenetics Institute Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 6073 USA

Department of Biochemistry McGill University Montreal QC H3A 1A3 Canada

Department of Human Genetics McGill University Montreal QC H3A 0C7 Canada

Department of Human Genetics McGill University Montreal QC H3A 0C7 Canada; Division of Experimental Medicine Department of Medicine McGill University Montreal QC H4A 3J1 Canada; Department of Pediatrics McGill University and The Research Institute of the McGill University Health Centre Montreal QC H4A 3J1 Canada

Department of Human Genetics McGill University Montreal QC H3A 0C7 Canada; Lady Davis Research Institute Jewish General Hospital Montreal QC H3T 1E2 Canada

Department of Medical Oncology Dana Farber Cancer Institute Boston MA 02215 5450 USA; Broad Institute of MIT and Harvard Boston MA 02142 USA

Department of Medical Oncology Dana Farber Cancer Institute Boston MA 02215 5450 USA; Department of Pathology Boston Children's Hospital and Brigham and Women's Hospital Harvard Medical School and Department of Oncologic Pathology Dana Farber Cancer Institute Boston MA 02115 USA

Department of Neuropathology Institute of Pathology University Hospital Heidelberg Heidelberg 69120 Germany; Clinical Cooperation Unit Neuropathology German Cancer Consortium Heidelberg 69120 Germany

Department of Neurosurgery University of Debrecen Debrecen 4032 Hungary

Department of Neurosurgery University of Debrecen Debrecen 4032 Hungary; Department of Oncology Faculty of Medicine University of Debrecen Debrecen 4032 Hungary

Department of Oncology and The Milner Institute Jeffrey Cheah Biomedical Centre University of Cambridge Cambridge CB2 0AW UK

Department of Oncology and The Milner Institute Jeffrey Cheah Biomedical Centre University of Cambridge Cambridge CB2 0AW UK; CRUK Children's Brain Tumour Centre of Excellence University of Cambridge Cambridge CB2 0RE UK

Department of Oncology and The Milner Institute Jeffrey Cheah Biomedical Centre University of Cambridge Cambridge CB2 0AW UK; Nuclear Function in CNS Pathophysiology German Center for Neurodegenerative Diseases Bonn 53127 Germany

Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague 150 06 Czech Republic

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University and University Hospital Motol Prague 150 06 Czech Republic

Department of Pathology Centre Hospitalier Universitaire Sainte Justine Université de Montréal Montréal QC H3T 1C5 Canada

Department of Pathology Montreal Children's Hospital McGill University Health Centre Montreal QC H4A 3J1 Canada

Department of Pathology Montreal Neurological Institute McGill University Montreal QC H3A 2B4 Canada

Department of Pediatric Neurosurgery Centre Hospitalier Universitaire Sainte Justine Université de Montréal Montréal QC H3T 1C5 Canada

Department of Pediatric Oncology Dana Farber Boston Children's Cancer and Blood Disorders Center Boston MA 02215 USA

Department of Pediatrics Division of Hematology and Oncology Texas Children's Cancer and Hematology Centers Dan L Duncan Cancer Center Baylor College of Medicine Houston TX 77030 USA

Department of Pediatrics McGill University and The Research Institute of the McGill University Health Centre Montreal QC H4A 3J1 Canada

Developmental and Stem Cell Biology Program The Hospital for Sick Children Toronto ON M5G 0A4 Canada; The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children Toronto ON M5G 0A4 Canada

Division of Experimental Medicine Department of Medicine McGill University Montreal QC H4A 3J1 Canada

Division of Pediatric Hematology and Oncology University Medical Center Goettingen Goettingen 37075 Germany

Division of Pediatric Hematology and Oncology University Medical Center Goettingen Goettingen 37075 Germany; Pediatric Glioma Research Group German Cancer Research Center 69120 Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Heidelberg 69120 Germany; Department of Pediatric Hematology and Oncology Heidelberg University Hospital Heidelberg 69120 Germany

Kids Cancer Centre Sydney Children's Hospital Randwick NSW 2031 Australia; School of Women's and Children's Health UNSW Sydney Kensington NSW 2052 Australia

Nuclear Function in CNS Pathophysiology German Center for Neurodegenerative Diseases Bonn 53127 Germany

Quantitative Life Sciences McGill University Montreal QC H3A 2A7 Canada; Lady Davis Research Institute Jewish General Hospital Montreal QC H3T 1E2 Canada

School of Computer Science McGill University Montreal QC H3A 2A7 Canada

UCL Queen Square Institute of Neurology London WC1N 3BG UK

See more in PubMed

Anderson AG, Kulkarni A, Harper M, and Konopka G (2020). Single-Cell Analysis of Foxp1-Driven Mechanisms Essential for Striatal Development. Cell reports 30, 3051–3066.e3057. PubMed PMC

Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, et al. (2009). Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108–112. PubMed PMC

Bolger AM, Lohse M, and Usadel B (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (Oxford, England) 30, 2114–2120. PubMed PMC

Bonev B, Mendelson Cohen N, Szabo Q, Fritsch L, Papadopoulos GL, Lubling Y, Xu X, Lv X, Hugnot J-P, Tanay A, et al. (2017). Multiscale 3D Genome Rewiring during Mouse Neural Development. Cell 171, 557–572.e524. PubMed PMC

Bourgey M, Dali R, Eveleigh R, Chen KC, Letourneau L, Fillon J, Michaud M, Caron M, Sandoval J, Lefebvre F, et al. (2019). GenPipes: an open-source framework for distributed and scalable genomic analyses. GigaScience 8. PubMed PMC

Butler A, Hoffman P, Smibert P, Papalexi E, and Satija R (2018). Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nature biotechnology 36, 411–420. PubMed PMC

Cameron CJ, Dostie J, and Blanchette M (2020). HIFI: estimating DNA-DNA interaction frequency from Hi-C data at restriction-fragment resolution. Genome biology 21, 1–15. PubMed PMC

Chapman H, Riesenberg A, Ehrman LA, Kohli V, Nardini D, Nakafuku M, Campbell K, and Waclaw RR (2018). Gsx transcription factors control neuronal versus glial specification in ventricular zone progenitors of the mouse lateral ganglionic eminence. Dev Biol 442, 115–126. PubMed PMC

Chapman H, Waclaw RR, Pei Z, Nakafuku M, and Campbell K (2013). The homeobox gene Gsx2 controls the timing of oligodendroglial fate specification in mouse lateral ganglionic eminence progenitors. Development 140, 2289–2298. PubMed PMC

Chen F, and LoTurco J (2012). A method for stable transgenesis of radial glia lineage in rat neocortex by piggyBac mediated transposition. Journal of neuroscience methods 207, 172–180. PubMed PMC

Christoforides A, Carpten JD, Weiss GJ, Demeure MJ, Von Hoff DD, and Craig DW (2013). Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC genomics 14, 302. PubMed PMC

Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, and Getz G (2013). Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature biotechnology 31, 213–219. PubMed PMC

Dali R, Bourque G, and Blanchette M (2018). RobusTAD: A Tool for Robust Annotation of Topologically Associating Domain Boundaries. bioRxiv, 293175.

Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, Hilton JA, Jain K, Baymuradov UK, Narayanan AK, et al. (2018). The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic acids research 46, D794–D801. PubMed PMC

DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, Del Angel G, Rivas MA, and Hanna M (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature genetics 43, 491. PubMed PMC

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, and Gingeras TR (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics (Oxford, England) 29, 15–21. PubMed PMC

Durand NC, Robinson JT, Shamim MS, Machol I, Mesirov JP, Lander ES, and Aiden EL (2016). Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom. Cell systems 3, 99–101. PubMed PMC

Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, et al. (2018). Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science (New York, NY) 360, 331–335. PubMed PMC

Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, Suva ML, and Bernstein BE (2016). Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114. PubMed PMC

Fontebasso AM, Gayden T, Nikbakht H, Neirinck M, Papillon-Cavanagh S, Majewski J, and Jabado N (2014a). Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathol 128, 615–627. PubMed PMC

Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, et al. (2014b). Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nature genetics 46, 462–466. PubMed PMC

Fontebasso AM, Schwartzentruber J, Khuong-Quang DA, Liu XY, Sturm D, Korshunov A, Jones DT, Witt H, Kool M, Albrecht S, et al. (2013). Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125, 659–669. PubMed PMC

Gessi M, Gielen GH, Hammes J, Dorner E, Muhlen AZ, Waha A, and Pietsch T (2013). H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? J Neurooncol 112, 67–72. PubMed

Hansen DV, Lui JH, Flandin P, Yoshikawa K, Rubenstein JL, Alvarez-Buylla A, and Kriegstein AR (2013). Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences. Nat Neurosci 16, 1576–1587. PubMed PMC

Hanzelmann S, Castelo R, and Guinney J (2013). GSVA: gene set variation analysis for microarray and RNA-seq data. BMC bioinformatics 14, 7. PubMed PMC

Harutyunyan AS, Krug B, Chen H, Papillon-Cavanagh S, Zeinieh M, De Jay N, Deshmukh S, Chen CCL, Belle J, Mikael LG, et al. (2019). H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis. Nat Commun 10, 1262. PubMed PMC

Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, et al. (2003). Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21, 4342–4349. PubMed

Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular cell 38, 576–589. PubMed PMC

Ip CKM, Ng PKS, Jeong KJ, Shao SH, Ju Z, Leonard PG, Hua X, Vellano CP, Woessner R, Sahni N, et al. (2018). Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. Nat Commun 9, 4583. PubMed PMC

Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M, Coutelier M, Faury D, Poreau B, De Jay N, Hebert S, Monlong J, et al. (2019). Stalled developmental programs at the root of pediatric brain tumors. Nature genetics 51, 1702–1713. PubMed PMC

Karch KR, Sidoli S, and Garcia BA (2016). Identification and quantification of histone PTMs using high-resolution mass spectrometry. In Methods in enzymology (Elsevier), pp. 3–29. PubMed PMC

Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, et al. (2012). K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124, 439–447. PubMed PMC

Kim S, Jeong K, Bhutani K, Lee J, Patel A, Scott E, Nam H, Lee H, Gleeson JG, and Bafna V (2013). Virmid: accurate detection of somatic mutations with sample impurity inference. Genome biology 14, R90. PubMed PMC

Kloetgen A, Thandapani P, Ntziachristos P, Ghebrechristos Y, Nomikou S, Lazaris C, Chen X, Hu H, Bakogianni S, Wang J, et al. (2020). Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nature genetics 52, 388–400. PubMed PMC

Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, and Wilson RK (2012). VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome research 22, 568–576. PubMed PMC

Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V, Sturm D, Meyer J, Jones C, Zheludkova O, et al. (2016). Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131, 137–146. PubMed

Koschmann C, Zamler D, MacKay A, Robinson D, Wu YM, Doherty R, Marini B, Tran D, Garton H, Muraszko K, et al. (2016). Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma. Oncotarget 7, 65696–65706. PubMed PMC

Krueger F (2012). Trim Galore: a wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files, with some extra functionality for MspI-digested RRBS-type (Reduced Representation Bisufite-Seq) libraries. URL http://www bioinformatics babraham ac uk/projects/trim_galore/(Date of access: 28/04/2016).

Krug B, De Jay N, Harutyunyan AS, Deshmukh S, Marchione DM, Guilhamon P, Bertrand KC, Mikael LG, McConechy MK, Chen CCL, et al. (2019). Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas. Cancer cell 35, 782–797 e788. PubMed PMC

Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, and Jang W (2018). ClinVar: improving access to variant interpretations and supporting evidence. Nucleic acids research 46, D1062–D1067. PubMed PMC

Langmead B, and Salzberg SL (2012). Fast gapped-read alignment with Bowtie 2. Nature methods 9, 357–359. PubMed PMC

Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, Dooling DJ, Ley TJ, Mardis ER, Wilson RK, and Ding L (2012). SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (Oxford, England) 28, 311–317. PubMed PMC

Larson JD, Kasper LH, Paugh BS, Jin H, Wu G, Kwon CH, Fan Y, Shaw TI, Silveira AB, Qu C, et al. (2019). Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer cell 35, 140–155 e147. PubMed PMC

Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, and Allis CD (2013). Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science (New York, NY) 340, 857–861. PubMed PMC

Li H, and Durbin R (2009). Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics (Oxford, England) 25, 1754–1760. PubMed PMC

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, and Durbin R (2009). The sequence alignment/map format and SAMtools. Bioinformatics (Oxford, England) 25, 2078–2079. PubMed PMC

Li S, Mattar P, Dixit R, Lawn SO, Wilkinson G, Kinch C, Eisenstat D, Kurrasch DM, Chan JA, and Schuurmans C (2014). RAS/ERK signaling controls proneural genetic programs in cortical development and gliomagenesis. J Neurosci 34, 2169–2190. PubMed PMC

Liao Y, Smyth GK, and Shi W (2014). featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics (Oxford, England) 30, 923–930. PubMed

Lindtner S, Catta-Preta R, Tian H, Su-Feher L, Price JD, Dickel DE, Greiner V, Silberberg SN, McKinsey GL, McManus MT, et al. (2019). Genomic Resolution of DLX-Orchestrated Transcriptional Circuits Driving Development of Forebrain GABAergic Neurons. Cell reports 28, 2048–2063.e2048. PubMed PMC

Liu XY, Gerges N, Korshunov A, Sabha N, Khuong-Quang DA, Fontebasso AM, Fleming A, Hadjadj D, Schwartzentruber J, Majewski J, et al. (2012). Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol 124, 615–625. PubMed

Lopez-Juarez A, Howard J, Ullom K, Howard L, Grande A, Pardo A, Waclaw R, Sun YY, Yang D, Kuan CY, et al. (2013). Gsx2 controls region-specific activation of neural stem cells and injury-induced neurogenesis in the adult subventricular zone. Genes Dev 27, 1272–1287. PubMed PMC

Love MI, Huber W, and Anders S (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550. PubMed PMC

Ma F, and Pellegrini M (2020). ACTINN: automated identification of cell types in single cell RNA sequencing. Bioinformatics (Oxford, England) 36, 533–538. PubMed

Ma T, Wang C, Wang L, Zhou X, Tian M, Zhang Q, Zhang Y, Li J, Liu Z, Cai Y, et al. (2013). Subcortical origins of human and monkey neocortical interneurons. Nat Neurosci 16, 1588–1597. PubMed

Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, et al. (2017). Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer cell 32, 520–537 e525. PubMed PMC

Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, and Martersteck EM (2015). Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214. PubMed PMC

Markovic-Mueller S, Stuttfeld E, Asthana M, Weinert T, Bliven S, Goldie KN, Kisko K, Capitani G, and Ballmer-Hofer K (2017). Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A. Structure 25, 341–352. PubMed

Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, and Hornischer K (2006). TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes. Nucleic acids research 34, D108–D110. PubMed PMC

McInnes L, Healy J, and Melville J (2018). Umap: Uniform manifold approximation and projection for dimension reduction. arXiv.

Mizrak D, Levitin HM, Delgado AC, Crotet V, Yuan J, Chaker Z, Silva-Vargas V, Sims PA, and Doetsch F (2019). Single-Cell Analysis of Regional Differences in Adult V-SVZ Neural Stem Cell Lineages. Cell reports 26, 394–406.e395. PubMed PMC

Nagy C, Maitra M, Tanti A, Suderman M, Théroux J-F, Mechawar N, Ragoussis J, and Turecki G (2019). Single-nucleus RNA sequencing shows convergent evidence from different cell types for altered synaptic plasticity in major depressive disorder. bioRxiv, 384479.

Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, et al. (2019). An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835–849.e821. PubMed PMC

Ngan CY, Wong CH, Tjong H, Wang W, Goldfeder RL, Choi C, He H, Gong L, Lin J, Urban B, et al. (2020). Chromatin interaction analyses elucidate the roles of PRC2-bound silencers in mouse development. Nature genetics 52, 264–272. PubMed PMC

Nitarska J, Smith JG, Sherlock WT, Hillege MM, Nott A, Barshop WD, Vashisht AA, Wohlschlegel JA, Mitter R, and Riccio A (2016). A Functional Switch of NuRD Chromatin Remodeling Complex Subunits Regulates Mouse Cortical Development. Cell reports 17, 1683–1698. PubMed PMC

Nowakowski TJ, Bhaduri A, Pollen AA, Alvarado B, Mostajo-Radji MA, Di Lullo E, Haeussler M, Sandoval-Espinosa C, Liu SJ, Velmeshev D, et al. (2017). Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science (New York, NY) 358, 1318–1323. PubMed PMC

Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science (New York, NY) 321, 1807–1812. PubMed PMC

Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P, Henderson S, Mikael LG, Richard-Londt A, Zhang Y, et al. (2017). H3.3(K27M) Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas. Cancer cell 32, 684–700.e689. PubMed PMC

Paugh BS, Zhu X, Qu C, Endersby R, Diaz AK, Zhang J, Bax DA, Carvalho D, Reis RM, Onar-Thomas A, et al. (2013). Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 73, 6219–6229. PubMed PMC

Petryniak MA, Potter GB, Rowitch DH, and Rubenstein JL (2007). Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron 55, 417–433. PubMed PMC

Pollen AA, Nowakowski TJ, Chen J, Retallack H, Sandoval-Espinosa C, Nicholas CR, Shuga J, Liu SJ, Oldham MC, Diaz A, et al. (2015). Molecular identity of human outer radial glia during cortical development. Cell 163, 55–67. PubMed PMC

Qiu X, Hill A, Packer J, Lin D, Ma Y-A, and Trapnell C (2017a). Single-cell mRNA quantification and differential analysis with Census. Nature methods 14, 309. PubMed PMC

Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, and Trapnell C (2017b). Reversed graph embedding resolves complex single-cell trajectories. Nature methods 14, 979. PubMed PMC

Quinlan AR, and Hall IM (2010). BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (Oxford, England) 26, 841–842. PubMed PMC

Raju CS, Spatazza J, Stanco A, Larimer P, Sorrells SF, Kelley KW, Nicholas CR, Paredes MF, Lui JH, Hasenstaub AR, et al. (2018). Secretagogin is Expressed by Developing Neocortical GABAergic Neurons in Humans but not Mice and Increases Neurite Arbor Size and Complexity. Cereb Cortex 28, 1946–1958. PubMed PMC

Ramsey SA, Knijnenburg TA, Kennedy KA, Zak DE, Gilchrist M, Gold ES, Johnson CD, Lampano AE, Litvak V, and Navarro G (2010). Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites. Bioinformatics (Oxford, England) 26, 2071–2075. PubMed PMC

Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, and Zhang F (2013). Genome engineering using the CRISPR-Cas9 system. Nature protocols 8, 2281. PubMed PMC

Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, Sanborn AL, Machol I, Omer AD, and Lander ES (2014). A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680. PubMed PMC

Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SRF, Wilkie AOM, McVean G, and Lunter G (2014). Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nature genetics 46, 912–918. PubMed PMC

Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, and Cheetham RK (2012). Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs. Bioinformatics (Oxford, England) 28, 1811–1817. PubMed

Schmitges FW, Prusty AB, Faty M, Stutzer A, Lingaraju GM, Aiwazian J, Sack R, Hess D, Li L, Zhou S, et al. (2011). Histone methylation by PRC2 is inhibited by active chromatin marks. Molecular cell 42, 330–341. PubMed

Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231. PubMed

Sergushichev AA (2016). An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv, 060012.

Shim AH-R, Liu H, Focia PJ, Chen X, Lin PC, and He X (2010). Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex. Proceedings of the National Academy of Sciences 107, 11307–11312. PubMed PMC

Shiraishi Y, Sato Y, Chiba K, Okuno Y, Nagata Y, Yoshida K, Shiba N, Hayashi Y, Kume H, Homma Y, et al. (2013). An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic acids research 41, e89. PubMed PMC

Sidoli S, Bhanu NV, Karch KR, Wang X, and Garcia BA (2016). Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. JoVE, e54112. PubMed PMC

Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, and Satija R (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888–1902.e1821. PubMed PMC

Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, et al. (2016). New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell 164, 1060–1072. PubMed PMC

Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tonjes M, Sill M, Bender S, et al. (2012). Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer cell 22, 425–437. PubMed

Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FM, Juraschka K, Farooq H, and Shibahara I (2019). Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. Nature 574, 707–711. PubMed PMC

Thorvaldsdóttir H, Robinson JT, and Mesirov JP (2013). Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Briefings in bioinformatics 14, 178–192. PubMed PMC

Tickle T, Tirosh I, Georgescu C, Brown M, and Haas B (2020). inferCNV of the Trinity CTAT Project (Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.).

Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, Bhaduri A, Goyal N, Rowitch DH, and Kriegstein AR (2019). Single-cell genomics identifies cell type-specific molecular changes in autism. Science (New York, NY) 364, 685–689. PubMed PMC

Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, Hovestadt V, Escalante LE, Shaw ML, Rodman C, et al. (2017). Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (New York, NY) 355. PubMed PMC

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell 17, 98–110. PubMed PMC

Visel A, Taher L, Girgis H, May D, Golonzhka O, Hoch RV, McKinsey GL, Pattabiraman K, Silberberg SN, Blow MJ, et al. (2013). A high-resolution enhancer atlas of the developing telencephalon. Cell 152, 895–908. PubMed PMC

Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC, et al. (2019). Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572, 67–73. PubMed PMC

Waltman L, and Van Eck NJ (2013). A smart local moving algorithm for large-scale modularity-based community detection. The European physical journal B 86, 471.

Wang K, Li M, and Hakonarson H (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research 38, e164–e164. PubMed PMC

Wen H, Li Y, Xi Y, Jiang S, Stratton S, Peng D, Tanaka K, Ren Y, Xia Z, Wu J, et al. (2014). ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. Nature 508, 263–268. PubMed PMC

Wingett S, Ewels P, Furlan-Magaril M, Nagano T, Schoenfelder S, Fraser P, and Andrews S (2015). HiCUP: pipeline for mapping and processing Hi-C data. In F1000Res, pp. 1310. PubMed PMC

Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al. (2012). Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature genetics 44, 251–253. PubMed PMC

Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y, Zhu X, Qu C, Chen X, Zhang J, et al. (2014). The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nature genetics 46, 444–450. PubMed PMC

Younesy H, Möller T, Lorincz MC, Karimi MM, and Jones SJM (2015). VisRseq: R-based visual framework for analysis of sequencing data. BMC bioinformatics 16, S2. PubMed PMC

Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, and Li W (2008). Model-based analysis of ChIP-Seq (MACS). Genome biology 9, R137. PubMed PMC

Zhang Y, Shan CM, Wang J, Bao K, Tong L, and Jia S (2017). Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation. Sci Rep 7, 43906. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...